Clinical Trial Update: Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing

View source ↗

Summary

A completed clinical trial investigating whether IgG level fluctuations after initial intravenous immunoglobulin treatment relate to subsequent dosing in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyneuropathy
• Multifocal Motor Neuropathy

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Walton Centre NHS Foundation Trust | Conditions: Multifocal Motor Neuropathy (MMN), Chronic Inflammatory Demyelinating Polyradiculoneuropathy | Status: COMPLETED